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Many veterans of the Vietnam War were
exposed to 2,3,7,8-tetrachlorodibenzo-p-
dioxin (TCDD or dioxin), which was present
as a contaminant in the herbicide formulation
Agent Orange [Booker 2001; Institute of
Medicine (IOM) 2000, 2003]. Indeed, signif-
icant residues of dioxin have been found in
their serum, even after many years, attesting
to the fact of their initial exposure and to the
long half-life of dioxin, which is estimated to
be 7.6 years (95% confidence interval,
7.0–8.2 years) (Michalek and Tripathi 1999).
Those dioxin residue levels are relatively high
among veterans of Operation Ranch Hand
(ORH) (Michalek and Tripathi 1999), the
operation responsible for the handling and
the actual aerial spraying of Agent Orange
and other dioxin-contaminated herbicides in
Vietnam from 1962 to 1971. Because of the
health implications, many epidemiologic
studies have been conducted to identify the
possible harmful effects of dioxin on exposed
veterans (Frumkin 2003; IOM 2000).
Among the recent findings, one of the most
consistently identified diseases statistically
associated with dioxin exposure is type 2 dia-
betes mellitus (Henriksen et al.1997;
Michalek et al. 1999). This conclusion is also
supported by the results of similar epidemio-
logic studies such as those of the population
exposed to high levels of dioxin in Seveso,
Italy (Bertazzi et al. 1998; Pesatori et al.
2003), industrial workers (Vena et al. 1998),
and Korean Vietnam veterans who were also
exposed to Agent Orange (Kim et al. 2003).
Despite the epidemiologic evidence for the
positive correlation, it has been difficult to
explain the mechanistic basis of action of
dioxin in causing type 2 diabetes in humans.
Because the actual levels of dioxin residues
among U.S. veterans are not as high as those
of the Seveso population (Bertazzi et al. 1998)
or the industrially exposed cohort (Vena et al.
1998) and because small amounts of dioxin
and dioxin-type chemicals are also found
among general populations in industrialized
nations, some scientists question the cause–
effect relationship between dioxin residues in
humans and an increased incidence of dia-
betes (Remillard and Bunce 2002). 
To address this important environmental
health question, we conducted a molecular
epidemiologic study on the state of expression
of selected biomarkers in adipose tissue sam-
ples from participants in the Air Force Health
Study. The Air Force Health Study was
designed to determine whether veterans of
ORH experienced adverse health effects and
whether those health effects, if they exist, can
be attributed to exposure to herbicides or their
dioxin contaminant (Wolfe et al. 1990). The
ORH veterans were exposed to herbicides dur-
ing flight operations, herbicide preparation,
and maintenance of the aircraft and herbicide
spray equipment. The examination content of
the Air Force Health Study emphasized detec-
tion of medical end points suspected of being
associated with exposure to dioxin, so exten-
sive data on health status and health behaviors
were collected on ORH veterans and a
matched comparison group of background-
exposed veterans. Adipose tissue was selected
for study because of its signiﬁcant role in the
etiology of type 2 diabetes (Scheen 2003).
Type 1 diabetes, considered genetic with onset
at an early age, was not included as an end
point in the Air Force Health Study protocol
and so was not considered in this study.
We hypothesized two possible pathways for
TCDD-induced glucose intolerance. In one
pathway involving oncogenes, Src [GenBank
accession no. M16243 (GenBank 2006)],
would activate MYC (GenBank accession no.
V00568; Jahner and Hunter 1991), which is a
direct controller of CCAAT/enhancer binding
protein-α (C/EBPα; GenBank accession no.
NM_004364; Freytag and Geddes 1992). Src
is known to be essential for TCDD-induced
wasting in mice (Dunlap et al. 2002), and
C/EBPα is a master switch for adipocytes that
causes the up-regulation of lipid accumulation
processes (MacDougald and Lane 1995). In
the other pathway, which involves inﬂamma-
tion, there would be increased production of
the cytokine tumor necrosis factor-α (TNF-α;
GenBank accession no. NM_000594), one of
the major mediators of dioxin-induced cell
inﬂammatory reactions (Alsharif et al. 1994;
Kern et al. 2002; Matsumura 2003; Taylor
et al. 1992). TNF-α is produced by adipocytes
also in response to obesity, causing increased
expression of the transcription factor NFκB,
and leading eventually to down-regulation of
the insulin receptor and the major insulin-
responsive glucose transporter GLUT4 (Halle
et al. 1998). To test the contributions of each
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BACKGROUND: One of the outcomes positively associated with dioxin exposure in humans is type 2
diabetes.
OBJECTIVES: This study was conducted in order to ﬁnd the molecular biological evidence for the
diabetogenic action of dioxin in adipose samples from Vietnam veterans.
METHODS: We obtained 313 adipose tissue samples both from Vietnam veterans who were exposed
to dioxin (Operation Ranch Hand) and from comparison veterans who served in Southeast Asia
with no record of dioxin exposure. We conducted quantitative reverse-transcribed polymerase chain
reaction studies on selected marker mRNAs from these samples.
RESULTS: We found the most sensitive and reliable molecular indicator of dioxin-induced diabetes
to be the ratio of mRNA of glucose transporter 4 (GLUT4) and nuclear transcription factor
kappa B (NFκB), a marker of inﬂammation. This ratio showed signiﬁcant correlations to serum
dioxin residues and to fasting glucose among those in the Ranch Hand group and, surprisingly,
even in the comparison group, who have low levels of dioxin comparable to the general public.
Such a correlation in the comparison group was particularly signiﬁcant among those with known
risk factors such as obesity and family history of diabetes.
CONCLUSIONS: These results show that the GLUT4:NFκB ratio is a reliable marker for the diabeto-
genic action of dioxin, particularly at very low exposure levels that are not much higher than those
found in the general public, implying a need to address current exposure levels.
KEY WORDS: adipose tissue, Agent Orange, biological markers, diabetes, fasting glucose, glucose
transporter type 4, inflammation, molecular epidemiology, NFκB, tetrachlorodibenzodioxin.
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http://dx.doi.org/ [Online 3 August 2006]pathway we measured mRNA expression of the
genes c-Src, C/EBPα, NFκB, and GLUT4 in
adipose tissue. In addition we measured
GAPDH, a housekeeping gene (Gorzelniak
et al. 2001), for use as a normalization standard
to correct for differences in cDNA synthesis
efﬁciency.
Materials and Methods
The details of basic study design and subject
selection have been published previously
(Wolfe et al. 1990). The Air Force Health
Study compares the health, mortality experi-
ence, and reproductive outcomes of ORH vet-
erans with a comparison group of other Air
Force veterans who served in Southeast Asia
during the same period (1962–1971) the
ORH unit was active but who were not
involved with spraying herbicides. Comparison
veterans were matched to ORH veterans on
date of birth, race (black, nonblack), and mili-
tary occupation (ofﬁcer pilot, ofﬁcer navigator,
nonﬂying ofﬁcer, enlisted ﬂyer, enlisted ground
crew). Periodic physical examinations and in-
person interviews were conducted in 1982,
1985, 1987, 1992, 1997, and 2002–2003.
The methods used in these studies were
approved by the institutional review boards at
the participating medical treatment facilities.
Participation was voluntary, and informed
consent was given by subjects at the examina-
tion sites.
Dioxin in serum collected from the veter-
ans in 1987 and 1992 was measured by the
Centers for Disease Control and Prevention
using high-resolution gas chromatography/
high resolution mass spectrometry (Patterson
et al. 1987). The between-assay coefﬁcient of
variation at three different concentrations of
dioxin ranged from 9.4% to 15.5%. For
those veterans whose serum dioxin level was
below the limit of detection, we assigned a
level equal to the detection limit divided by
the square root of 2 (Hornung and Reed
1990). Dioxin results were expressed in parts
per trillion on a serum lipid weight basis.
Fasting glucose (milligrams per deciliter) was
determined with Paramax equipment (model
720 ZX; Baxter Scientific Instruments,
Deerfield, IL). Body mass index (BMI) was
defined as weight divided by the square of
height, and percent body fat (PBF) was
deﬁned as (1.264 × BMI) – 13.305 (Knapik
et al. 1983). 
Before the commencement of the 1997
physical examination, 650 veterans were ran-
domly selected according to a four-way factorial
deﬁned by service group (ORH, comparison),
diabetic status (diabetic, nondiabetic), age
(young, born during or after 1942; old, born
before 1942), and body fat (lean, PBF ≤ 25;
obese, PBF > 25) from those who had been
compliant in the 1992 examination (n = 2,233)
after excluding those who had a missing dioxin
measurement (n = 78) or diabetes prior to ser-
vice in Southeast Asia (n = 5), died (n = 55), or
refused to participate (n = 6). The desired sam-
ple size (n = 650) represented 31.12% of the
eligible veterans (n = 2,089), and a sample
including approximately 31.12% was ran-
domly selected from each of the 16 cells. Final
numbers are shown in Table 1. Type 2 dia-
betes mellitus cases were diagnosed during the
post-Vietnam period from the end of the vet-
eran’s last tour of duty to 31 December 2000.
Veterans who had a verified history of dia-
betes by medical diagnosis or exhibited a 2-hr
postprandial glucose laboratory value of
≥ 200 mg/dL were classified as diabetic.
Veterans not meeting these criteria were
deﬁned as nondiabetic. 
At the 1997 examination, the selected
veterans were invited to submit to an extrac-
tion of 2–15 g of lateral abdominal subcuta-
neous adipose tissue by liposuction. Of these,
107 were excluded because of medications
they were taking, 106 were determined to be
too lean, 66 refused, 3 were medically
deferred, 1 could not be scheduled, and
54 were not asked, leaving 313 to complete
the procedure. The specimens were flash
frozen in liquid nitrogen at the clinic and
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Table 1. Sample sizes and demographics.
Group/diabetic Age Lean Obese Total
status category (n)( n)( n)
Comparison 
Nondiabetic Young 58 18 76
Old 56 24 80
Diabetic Young 3 7 10
Old 9 9 18
ORH
Nondiabetic Young 46 13 59
Old 40 11 51
Diabetic Young 4 4 8
Old 6 5 11
Total 313
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Figure 1. The GLUT4:NFκB ratio versus change in PBF from 1992 to 1997. Abbreviations: C, comparison; D,
diabetic; F, family history of diabetes; ND, nondiabetic; NF, no family history of diabetes. Transforms:
GLUT4:NFκB, log10(x); change in PBF, (x + 30)1/2. (A) Comparison and ORH, ND (r = –0.21; p < 0.001).
(B) Comparison and ORH, D (r = 0.06; p = 0.68). (C) Comparison, ND, NF (r = 0.04, p = 0.7). (D) ORH, ND, NF
(r = –0.34, p = 0.003). (E) Comparison, ND, F (r = –0.33, p = 0.03). (F) ORH, ND, F (r = –0.31, p = 0.11). (A) and
(B) slopes are different (p = 0.03); (C) and (D) slopes are different (p = 0.02); (C) and (E) slopes are different
(p = 0.05); (F) slope is not different from (C) slope (p = 0.16) or (E) slope (p = 0.51). Correlations are partial;
they and interaction p-values were adjusted for age.
Fujiyoshi et al.shipped to the laboratory in dry ice, thawed
on ice, washed in sterile phosphate buffer
solution to remove blood, refrozen, and
stored at –80°C until sample analysis.
We extracted RNA from approximately
500 mg tissue from each sample using TRIzol
LS (Invitrogen, Carlsbad, CA), followed by a
digest with RNase-free DNase I (Roche
Applied Science, Indianapolis, IN) and a repeat
extraction. The yield of RNA was determined
spectrophotometrically. Specimens from two
individuals were used up in preliminary stud-
ies. We synthesized cDNA from 1 µg total
RNA using the Omniscript RT Kit (Qiagen,
Valencia, CA), modifying the kit instructions
by doubling the Oligo-dT primer and 10X
buffer amounts and adjusting the water
amount to yield 40 µl total volume.
Using conventional Taq DNA polymerase
(Qiagen), 99 cDNA samples were ampliﬁed in
duplicate to reduce variation due to saturation
effects. Ampliﬁed fragments were separated on
a 1% agarose gel alongside a DNA ladder of
100-bp increments, which was included to
confirm fragment molecular weights. Band
density was quantified digitally using the
ChemiImager 4400, version 5.5 (Alpha
Innotech, San Leandro, CA). Primers used for
GAPDH, c-Src, and NFκB were previously
described (Ercolani et al. 1988; Kubota et al.
2001; Meyer et al. 1991), whereas we
designed primers for C/EBPα [5´-TTCCG-
GTGCCTCCTGAAAGC-3´ (sense) and
5´-ACAGCCAGATCTCTAGGTCT-3´
(antisense)] and GLUT4 [5´-CAACTG-
GACGAGCAACTTCA-3´ (sense) and
5´-CCAGCTTCCCAATTCTACCA-3´
(antisense)]. Ampliﬁcation conditions were as
follows: 2 min initial denaturation at 94°C,
cycling steps of 1 min denaturation at 94°C,
1 min annealing, and 1 min elongation at
72°C, ending with 10 min ﬁnal elongation at
72°C. Annealing temperatures and cycle
numbers were 60°C and 25 for GAPDH and
C/EBPα; 55°C and 25 for c-Src; 60°C and 30
for GLUT4; and 62°C and 32 for NFκB.
One sample was designated as the internal
standard for polymerase chain reaction (PCR)
and repeated in each run and on each gel in
order to compare between runs. 
The remaining 212 cDNA samples were
analyzed without duplication by real-time PCR
on the LightCycler (Roche Applied Science)
using the QuantiTect SYBR Green PCR kit
(Qiagen) (Vogel et al. 2005) for GAPDH,
c-Src, and GLUT4, and LightCycler FastStart
DNA Master SYBR Green I (Roche Applied
Science) for C/EBPα and NFκB. We designed
a new GAPDH primer pair using PRIMER 3
(Rozen and Skaletsky 2000): 5´-GAGT-
CAACGGATTTGGTCGT-3´ (sense) and
5´-TTGATTTTGGAGGGATCTCG-3´
(antisense). PCR conditions followed kit
instructions, with annealing temperatures and
extension times of 54°C and 12 sec for
GAPDH, 53°C and 28 sec for c-Src, 55°C and
20 sec for GLUT4, 60°C and 28 sec for
C/EBPα, and 62°C and 17 sec for NFκB. We
increased the magnesium chloride concentra-
tion for the LightCycler kit to 4 mM, and the
PCR product size was checked on a 1%
agarose gel. We calculated relative sample con-
centrations from crossing point data using the
transform 2–x. To make LightCycler-deter-
mined values from different runs comparable
to each other and to conventional values, we
reran subsets of samples from each run in a
common run.
We performed general linear model statis-
tical analysis using SAS software, version 9.1
for Windows (SAS Institute, Cary, NC). We
considered and dismissed main effects models
of PCR values in terms of dioxin with adjust-
ment for age, body fat, diabetic status, and
exposure group because none of these yielded
significant results. Subsequently, interaction
models involving the product of dioxin with
age, body fat, and group were considered;
many of these indicated significant inter-
actions, motivating stratiﬁcation. PCR values
were transformed for analysis using various
log and power transforms as needed to
remove skewness. For purpose of analysis,
body fat categories of lean and obese were
based on 1997 measurements. All statistical
testing was two-sided, with a signiﬁcance level
of p = 0.05.
Results
Raw mRNA values for expression of the four
genes studied, before GAPDH normalization,
had interquartile ranges of 2.2-fold for
C/EBPα, 3.3-fold for NFκB, 3.4-fold for
GLUT4, and 3.6-fold for c-Src. By compari-
son, the interquartile range for GAPDH was
> 6-fold. GAPDH-normalized gene expres-
sion values for c-Src, NFκB, and C/EBPα,
after transformation, were signiﬁcantly nega-
tively correlated with transformed GAPDH
values p < 0.001). 
One of the most statistically signiﬁcant cor-
relations of mRNA expressions or their ratios to
change in PBF was the ratio of GLUT4 to
NFκB (GLUT4:NFκB ratio) among combined
nondiabetic subjects at p < 0.001 (Figure 1A).
The ratio of GLUT4 to C/EBPα (p = 0.002,
data not shown) and the ratio of Src to NFκB
(p = 0.031, data not shown) also showed signiﬁ-
cant correlations to PBF in the same popula-
tion. In all cases the value of the ratio tended to
drop with increasing PBF among nondiabetic
subjects, as shown in Figure 1A compared with
the corresponding diabetic subjects, which
showed no relationship (e.g., Figure 2B). The
differences in these ratios between the non-
diabetic and diabetic populations were signiﬁ-
cant in all three cases. To increase the sensitivity
of detection of this physiologic change, we
adopted the GLUT4:NFκB ratio as the main
marker. Further analyses of nondiabetic sub-
groups using the same GLUT4:NFκB ratio
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Figure 2. Effect of dioxin load, stratiﬁed by quartile, on selected mRNA expression parameters in adipose
tissue of nondiabetic subjects by exposure group. Abbreviations: C, comparison; ND, nondiabetic.
Transforms: GLUT4:GAPDH, log10(0.1 + x); NFκB:GAPDH, log10(2 + x); GLUT4:NFκB, log10(x); dioxin,
1 + log10(x – 0.5). (A) GLUT4:GAPDH (C trend, p = 0.38; ORH trend p = 0.05) (B) NFκB:GAPDH (C trend, p = 0.16;
ORH trend, p = 0.18. (C) GLUT4:NFκB (C trend, p = 0.07; ORH trend, p = 0.02). Least square means, trend
p-values, and quartile contrasts were adjusted for age and PBF.
*p < 0.05, and **p < 0.01 compared with the mean for the lowest dioxin quartile.showed that, among nondiabetic individuals in
the comparison group without family history
of diabetes, there was actually no negative or
positive correlation to body weight change
(Figure 1C). In contrast, among the corre-
sponding subgroup (nondiabetic with no fam-
ily history of diabetes) in the ORH group
(Figure 1D), we found a signiﬁcant negative
correlation (p = 0.003). Even among nondia-
betic comparison subjects, those with a family
history of diabetes showed a negative slope
(Figure 1E; p = 0.03), which was also statisti-
cally different (p = 0.05) from the slope in
Figure 1C.
To study the effect of dioxin on the expres-
sion of each marker, we subdivided each group
into quartiles according to measured levels of
serum dioxin residues and compared gene
expression ratios among nondiabetic individu-
als of these subgroups. GLUT4:GAPDH and
NFκB:GAPDH ratios showed signiﬁcant dif-
ferences among quartiles (Figure 2A,B). A
similar result was obtained when GLUT4 was
compared to C/EBPa instead of GAPDH
(data not shown). However, the ratio that gave
us the clearest trend with dioxin was again
GLUT4:NFκB (Figure 2C). The most con-
spicuous difference between the two service
groups was the direction of slopes. Veterans of
the ﬁrst quartile of the comparison group had
a significantly higher GLUT4:NFκB ratio
than those of the second and third dioxin
quartiles, exhibiting a negative relationship to
dioxin residues; in contrast, Agent Orange-
exposed ORH subjects clearly showed a posi-
tive trend. Among comparison subjects, only
the highest dioxin residue quartile contra-
dicted the downward trend. 
In view of this ﬁnding, we further analyzed
the relationships between the GLUT4:NFκB
ratio and dioxin exposure in the full cohort of
veterans (Figure 3A vs. Figure 3B). In general,
dioxin was associated with an increase in the
GLUT4:NFκB ratio in the ORH group,
whereas there was no trend in the comparison
group. Further analyses of several subgroups
within each service group revealed that the
GLUT4:NFκB ratio tended to decline when
serum dioxin increased among nondiabetic
individuals in the comparison group who are
obese and have a family history of diabetes
(Figure 3C). Other subgroups that showed sig-
nificantly different GLUT4:NFκB responses
to increasing serum dioxin were the combined
(comparison + ORH) subgroup consisting of
obese subjects with a family history of diabetes
(Figure 3D) compared with the combined sub-
group of lean subjects with a family history of
diabetes (Figure 3E).
To test the validity of using the
GLUT4:NFκB ratio as a molecular parameter
to assess diabetogenic conditions, we analyzed
its relationship to the high levels of serum
glucose after fasting (fasting glucose). As seen
in Figure 4A, the fasting glucose levels stayed
within a narrow range of values among all
(comparison + ORH) nondiabetic study sub-
jects over the wide range of GLUT4:NFκB
ratios, as expected. In contrast, among all dia-
betic subjects (Figure 4B), those with lower
GLUT4:NFκB ratios exhibited higher fasting
glucose levels. We further checked the relation-
ship between PBF and fasting glucose levels in
all nondiabetic subjects (Figure 4C) com-
pared with all diabetic subjects (Figure 4D).
We found a significant relationship in non-
diabetic subjects (r = 0.27, p < 0.001) but not
in diabetic subjects (r = –0.05, p = 0.73). 
Next, we studied the relationship between
the levels of fasting glucose and serum dioxin
to further test our premise that dioxin acts as a
diabetogenic agent. When both nondiabetic
and diabetic subjects were combined within
each service group, we found a positive correla-
tion between fasting glucose and serum dioxin
levels in the comparison group (Figure 4E;
p = 0.02). In contrast, these two parameters
were not correlated in the corresponding ORH
subgroup (Figure 4F). 
Discussion
Initially we conducted a preliminary survey of
the expressions of the proposed markers in all
samples to see which markers or their combi-
nations would give a reliable indication of
physiologic conditions leading to diabetes. To
aid in this process, we formulated a working
hypothesis that the diabetogenic action of
TCDD could be phenotypically similar to
that of obesity. Therefore, we studied the rela-
tionship between mRNA expression of those
selected markers and PBF gain over the last
5 years among veterans. Of all of the molecu-
lar markers and their combinations examined,
the most readily recognizable gene expression
effects were those of the GLUT4:NFκB ratio
Fujiyoshi et al.
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in response to the presence of dioxin, as
assessed in the serum of the veterans. This
observation agrees well with the generally
accepted view that in the case of obesity-
induced type 2 diabetes TNF-α plays the cen-
tral role through its action to activate NFκB,
which down-regulates GLUT4 (Ruan et al.
2002). Theoretically, if the TNF-α–NFκB
pathway is activated, a rise in NFκB expres-
sion will lead to a drop in GLUT4 expres-
sion; thus, the ratio is expected to be more
responsive than either individual gene nor-
malized by a housekeeping gene. The trends
for GLUT4:C/EBPα and Src:NFκB may rep-
resent merely weaker responses of ratios that
contain the GLUT4 or NFκB component of
the GLUT4:NFκB ratio. 
This GLUT4:NFκB ratio marker approach
was most effective in detecting the effect of
dioxin at low-to-medium levels of exposure,
corresponding to the lower three quartiles in
the comparison group (Figure 1). This range
of dioxin levels corresponds to 1–5.3 ppt. In
fact the highest dioxin level for the entire com-
parison group is 16.3 ppt. The level of dioxin
in serum lipids among U.S. workers that
Sweeney et al. (1997–1998) found in their
comparison group was 0–20 ppt, indicating
that the range we found in the comparison
group in the present study was not much dif-
ferent from that of the general public in the
United States. In this regard, it is important to
point out that we found significant signs of
dioxin-correlated diabetogenic tendency
among comparison group subjects with low
levels of dioxin, particularly in those with
genetic (family history of diabetes) and physi-
ologic (obesity) risk factors (Figure 3C).
Furthermore, dioxin, even at this low concen-
tration range, definitely has an effect on the
levels of fasting glucose (Figure 4E). The
GLUT4:NFκB response to dioxin exposure
levels found in the lower three quartiles of the
comparison group also agrees well with the
data obtained from cell models (Ruan et al.
2002) and animal models (Dunlap et al. 2002;
Liu and Matsumura 1995).
The observation that the GLUT4:NFκB
ratio declined with weight gain, independent
of exposure history (Figure 1A) and with
higher serum dioxin residues among compari-
son individuals (Figure 2C), particularly obese
individuals with family history of diabetes
(Figure 3C), suggests that dioxin works syner-
gistically with known diabetes risk factors to
alter glucose metabolism in a way that resem-
bles the inflammation mechanism of weight
gain. The GLUT4:NFκB ratio appears to be
a useful biomarker for the detection of the
diabetogenic action of these factors. The
inﬂammation mechanism also seems to oper-
ate at low background levels of dioxin, as seen
in the three lowest serum dioxin quartiles
(i.e., those with ≤ 5.3 ppt) of the larger group
of background-exposed veterans (Figure 2C).
Such an observation alone would not consti-
tute a proof for the identical action mecha-
nism of dioxin to diabetogenic action of
obesity, but it allows us to formulate a
hypothesis along this line of logic to help our
future studies. 
We found the GLUT4:NFκB ratio to be
a reliable parameter in assessing the state of
diabetes. Diabetic subjects with lowered
GLUT4:NFκB were less able to regulate
blood glucose, whereas nondiabetic subjects
maintained fasting glucose levels within a
narrow range of values, independent of
GLUT4:NFκB (Figure 4A,B). However, our
ﬁnding regarding this effect of GLUT4:NFκB
was somewhat surprising in view of the lack of
correlation of GLUT4:NFκB with weight
gain among diabetic subjects (Figure 1B); this
finding suggests that once the study subjects
develop diabetes, the GLUT4:NFκB ratio
does not work well as a biomarker for obesity.
However, the GLUT4:NFκB ratio does work
as a biomarker for elevated fasting glucose
(Figure 4B). The important message derived
from Figure 4B is that the workable range or
the usefulness of the GLUT4:NFκB ratio as a
biomarker depends largely on the factor
against which it is being regressed. Thus, one
should not assume automatically that the state
of disease makes it impossible to use this bio-
marker on all diabetes-related cellular changes. 
Among nondiabetic veterans without a
family history of diabetes (i.e., healthy sub-
population) in the comparison group, we
found no detectable effect of obesity on the
GLUT4:NFκB ratio (Figure 1C), indicating
the existence of normal homeostatic control.
In contrast, the corresponding subgroup from
the ORH group clearly showed the effect of
obesity (Figure 1D) as though they already
had the genetic risk factor, as in the case of the
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subgroup with a family history of diabetes in
the comparison group (Figure 1E). This set of
data also supports our interpretation that dioxin
acts as one of the risk factors for diabetes.
As we expected, fasting glucose levels were
reliable parameters in judging the diabetogenic
effects of obesity among nondiabetic subjects
(Figure 4C) at the early stage of developing
diabetes but not at the later stage, as seen in
diabetic subjects (Figure 4D). In addition, the
observation that fasting glucose is higher
among subjects in the comparison group who
had higher serum dioxin levels complements
the observation of Henriksen et al. (1997),
who found increased fasting glucose with
higher levels of dioxin in a larger cohort of
Agent Orange–exposed veterans.
The decrease in the expression of GLUT4
in adipose tissue has been shown to be associ-
ated with non–insulin-dependent diabetes.
Minokoshi et al. (2003) found that tissue-
speciﬁc ablation of GLUT4 and insulin recep-
tor in adipose tissue or muscle in mice led to
insulin resistance and diabetes in the mice
lacking adipose GLUT4 expression but not in
those missing GLUT4 only in muscles. In
humans, Garvey et al. (1991) found that an
80% decrease in GLUT4 protein per cell in
the adipocytes of diabetic subjects compared
with lean nondiabetic controls was associated
with a 56% decrease in maximally insulin-
stimulated glucose uptake. The level of
GLUT4 mRNA was correlated with the
amount of GLUT4 protein (r = 0.77) in their
controls but not in their diabetic subjects.
There are also precedents indicating that
the change in NFκB is correlated to diabetes.
NFκB is a nuclear transcription factor that is
known to be activated by inﬂammatory signal-
ing of several agents, including TNF-α, and to
transmit their messages into the nucleus.
Although we did not include TNF-α in the
present study, its involvement in the toxic
action of dioxin is well known (Alsharif et al.
1994; Taylor et al. 1992). TNF-α is one of
the major mediators of dioxin-induced cell
inflammatory reactions (Matsumura 2003).
Furthermore, the role of TNF-α in the
development of insulin resistance and type 2
diabetes, particularly in the case of obesity-
induced diabetes, is now becoming well recog-
nized (Das 1999). Indeed, obesity induces
increased expression of TNF-α and NFκB,
leading to down-regulation of insulin receptor
and decreasing expression of GLUT4 (Halle
et al. 1998). Our observation in the present
study that the GLUT4:NFκB ratio dramati-
cally decreases among nondiabetic veterans who
experienced a relatively recent increase in body
fat attests to the correctness of this diagnosis.
We did not include measurements of
other compounds with dioxin-like activity
because these were not available in this popu-
lation until well after the period of this study.
Sweeney et al. (1997–1998) found that use of
toxic equivalents (TEQ; the body burden of
TCDD-equivalent activity from all com-
pounds) led to a narrowing of the differences
between acute- and background-exposed
populations. Furthermore, the phenoxy herbi-
cides in the Agent Orange formulation are
known peroxisome proliferators and thus may
have antidiabetic action (Remillard and Bunce
2002). With such confounding factors acting
to obscure the effects of TCDD, the results we
did ﬁnd are all the more noteworthy.
One major question that remains unan-
swered is why the overall relationship between
the GLUT4:NFκB ratio and serum dioxin
levels show the “V” shape (Figure 2C), indi-
cating a reversal of dioxin’s effect at levels
higher than the background range. This is
puzzling because, in all other cases, either the
GLUT4:NFκB ratio or dioxin levels showed
straightforward relationships to other parame-
ters analyzed. One possibility is that veterans
with dioxin residue levels > 5.3 ppt are experi-
encing the effects of cachexia, a typical effect
of dioxin exposure. It involves massive loss of
adipose tissues in most animals studied,
including humans (Matsumura 2003). In this
regard, it is interesting to note the similarities
in the direction of slopes between Figure 3A
and Figure 3D, and between Figure 3B and
Figure 3E, indicating that as a whole, com-
parison subjects are similar to combined
(comparison + ORH) nondiabetic obese sub-
jects with a family history of diabetes with
respect to their GLUT4:NFκB response to
dioxin. In the same manner, ORH subjects
are similar to combined (comparison + ORH)
nondiabetic lean subjects with family history
of diabetes, despite the fact that there is no
difference in the frequency of obesity between
comparison and ORH subjects. Such an
observation favors the view that wasting syn-
drome is already taking place among those
exposed to high levels of dioxin and that
ORH subjects as a whole are responding to
dioxin as though they were lean. Another pos-
sibility is that in human adipose tissues,
unlike the case of mice, chronic exposure to
high concentrations of dioxin could trigger a
strong negative feedback reaction through
activation of major “negative regulators” to
counteract excessive inflammatory insults.
The observation that three of the parameters
we studied, NFκB, C/EBPα, and GLUT4
expression, show this phenomenon of “rever-
sal” at high dioxin concentrations > 5.3 ppt
supports this interpretation. Nevertheless,
much more work is needed to prove or dis-
prove these hypotheses. It is also important to
point out that, despite the above “reversal”
phenomenon in the relationship between
GLUT4:NFκB ratio and dioxin, all non-
diabetic individuals with significant dioxin
residues, including those with residue levels
> 5.3 ppt, still show the clear sign of the obe-
sity-related risk of diabetes, judging by the
results of experiments shown in Figure 4C.
Conclusions
In conclusion, by using this molecular epi-
demiologic approach we found deﬁnitive evi-
dence indicating that a diabetogenic shift
occurred in the biochemistry of adipose tis-
sues from Vietnam veterans who were
exposed to dioxin-containing Agent Orange
herbicide preparations. Such a diabetogenic
effect of dioxin was observed even among
comparison group veterans, particularly those
with diabetes risk factors such as obesity
and/or a family history of diabetes, despite the
fact that their levels of exposure are not really
different from those of the general public in
the United States. The major implication of
the present study is, therefore, that the poten-
tial health hazard of dioxin and active dioxin-
type chemicals, even at the current level of
public exposure, must be taken seriously.
Further research is needed to fully elucidate
the precise mechanism through which dioxin
promotes type 2 diabetes in humans.
REFERENCES
Alsharif NZ, Hassoun E, Bagchi M, Lawson T, Stohs SJ. 1994.
The effects of anti-TNF-alpha antibody and dexamethasone
on TCDD-induced oxidative stress in mice. Pharmacology
48:127–136.
Bertazzi PA, Bernucci I, Brambilla G, Consonni D, Pesatori AC.
1998. The Seveso studies on early and long-term effects of
dioxin exposure: a review. Environ Health Perspect
106(suppl 2):625–633.
Booker SM. 2001. Dioxin in Vietnam: fighting a legacy war.
Environ Health Perspect 109:A116–A117.
Das UN. 1999. GLUT-4, tumor necrosis factor, essential fatty
acids and daf-genes and their role in insulin resistance and
non-insulin dependent diabetes mellitus. Prostglandins
Leukot Essent Fatty Acids 60:13–20.
Dunlap DY, Ikeda I, Nagashima H, Vogel CF, Matsumura F. 2002.
Effects of src-deﬁciency on the expression of in vitro toxicity
of TCDD in a strain of c-src knockout mice procured through
six generations of backcrossings to C57BL/6 mice.
Toxicology 172:125–141.
Ercolani L, Florence B, Denaro M, Alexander M. 1988.
Isolation and complete sequence of a functional glycer-
aldehyde-3-phosphate dehydrogenase gene. J Biol
Chem 263:15335–15341.
Freytag SO, Geddes TJ. 1992. Reciprocal regulation of adipo-
genesis by Myc and C/EBP alpha. Science 256:379–382.
Frumkin H. 2003. Agent Orange and cancer: an overview for
clinicians. CA Cancer J Clin 53:245–255.
Garvey WT, Maianu L, Huecksteadt TP, Birnbaum MJ,
Molina JM, Ciaraldi TP. 1991. Pretranslational suppression
of a glucose transporter protein causes insulin resistance
in adipocytes from patients with non-insulin-dependent
diabetes mellitus and obesity. J Clin Invest 87:1072–1081.
GenBank. 2006. GenBank Overview. Available: http://www.ncbi.
nlm.nih.gov/Genbank/index.html [accessed 18 September
2006].
Gorzelniak K, Janke J, Engeli S, Sharma AM. 2001. Validation
of endogenous controls for gene expression studies in
human adipocytes and preadipocytes. Horm Metab Res
33:625–627.
Halle M, Berg A, Northoff H, Keul J. 1998. Importance of TNF-
alpha and leptin in obesity and insulin resistance: a
hypothesis on the impact of physical exercise. Exerc
Immunol Rev 4:77–94.
Henriksen GL, Ketchum NS, Michalek JE, Swaby JA. 1997.
Serum dioxin and diabetes mellitus in veterans of
Operation Ranch Hand. Epidemiology 8:252–258.Hornung RW, Reed DR. 1990. Estimation of average concentra-
tion in the presence of nondetectable values. App Occup
Environ Hyg 5:46–51.
Institute of Medicine. 2000. Veterans and Agent Orange:
Update 2000. Washington, DC:National Academy Press.
Institute of Medicine. 2003, Veterans and Agent Orange:
Update 2002. Washington, DC:National Academy Press.
Jahner D, Hunter T. 1991. The stimulation of quiescent rat ﬁbro-
blasts by v-src and v-fps oncogenic protein-tyrosine
kinases leads to the induction of a subset of immediate
early genes. Oncogene 6:1259–1268.
Kern PA, Dicker-Brown A, Said ST, Kennedy R, Fonseca VA. 2002.
The stimulation of tumor necrosis factor and inhibition of
glucose transport and lipoprotein lipase in adipose cells by
2,3,7,8-tetrachlorodibenzo-p-dioxin. Metabolism 51:65–68.
Kim JS, Lim HS, Cho SI, Cheong HK, Lim MK. 2003. Impact of
Agent Orange exposure among Korean Vietnam veterans.
Ind Health 41:149–157.
Knapik JJ, Burse RL, Vogel JA. 1983. Height, weight, percent
body fat, and indices of adiposity for young men and women
entering the US Army. Aviat Space Environ Med 54:223–231.
Kubota Y, Tanaka T, Kitanaka A, Ohnishi H, Okutani Y, Waki M,
et al. 2001. Src transduces erythropoietin-induced differenti-
ation signals through phosphatidylinositol 3-kinase. EMBO J
20:5666–5677.
Liu PC, Matsumura F. 1995. Differential effects of 2,3,7,8-tetra-
chlorodibenzo-p-dioxin on the “adipose –type” and “brain-
type” glucose transporters in mice. Mol Pharmacol 47:65–73.
MacDougald OA, Lane MD. 1995. Transcriptional regulation of
gene expression during adipocyte differentiation. Annu
Rev Biochem 64:345–373.
Matsumura F. 2003. On the significance of the role of cellular
stress response reactions in the toxic actions of dioxin.
Biochem Pharmacol 66:527–540.
Meyer R, Hatada EN, Hohmann HP, Haiker M, Bartsch C,
Rothlisberger U, et al. 1991. Cloning of the DNA-binding
subunit of human nuclear factor kappa B: the level of its
mRNA is strongly regulated by phorbol ester or tumor
necrosis factor alpha. Proc Natl Acad Sci USA 88:966–970.
Michalek JE, Akhtar FZ, Kiel JL. 1999. Serum dioxin, insulin, fast-
ing glucose, and sex hormone binding globulin in veterans
of Operation Ranch Hand. J Clin Endocrinol Metab
84:1540–1543.
Michalek JE, Tripathi RC. 1999. Pharmacokinetics of TCDD in
veterans of Operation Ranch Hand: 15-year follow-up.
J Toxicol Environ Health A57:369–378.
Minokoshi Y, Kahn CR, Kahn BB. 2003. Tissue-speciﬁc ablation
of the GLUT4 glucose transporter or the insulin receptor
challenges assumptions about insulin action and glucose
homeostasis. J Biol Chem 278:33609–33612.
Patterson DG Jr, Hampton L, Lapeza CR Jr, Belser WT, Green V,
Alexander L, et al. 1987. High-resolution gas chromato-
graphic/high-resolution mass spectrometric analysis of
human serum on a whole-weight and lipid basis for 2,3,7,8-
tetrachlorodibenzo-p-dioxin. Anal Chem 59:2000–2005.
Pesatori AC, Consonni D, Bachetti S, Zochetti C, Bonzini M,
Baccarelli A, et al. 2003. Short- and long-term morbidity
and mortality in the population exposed to dioxin after the
‘Seveso Accident’. Ind Health 41:127–138.
Remillard RB, Bunce NJ. 2002. Linking dioxins to diabetes: epi-
demiology and biologic plausibility. Environ Health
Perspect 110:853–858.
Rozen S, Skaletsky HJ. 2000. PRIMER 3 on the WWW for general
users and for biologist programmers. In: Bioinformatics
Methods and Protocols: Methods in Molecular Biology
(Krawetz S, Misener S, eds). Totowa, NJ:Humana Press,
365–386.
Ruan H, Hacohen N, Golub TR, Van Parijs L, Lodish HF. 2002.
Tumor necrosis factor-alpha suppresses adipocyte-speciﬁc
genes and activates expression of preadipocyte genes in
3T3-L1 adipocytes: nuclear factor-kappaB activation by
TNF-alpha is obligatory. Diabetes 51:1319–1336.
Scheen AJ. 2003. Pathophysiology of type 2 diabetes. Acta Clin
Belg 58:335–341.
Sweeney MH, Calvert GM, Egeland GA, Fingerhut MA,
Halperin WE, Piacitelli LA. 1997–1998. Review and update of
the results of the NIOSH medical study of workers exposed
to chemicals contaminated with 2,3,7,8-tetrachlorodibenzo-
dioxin. Teratog Carcinog Mutagen 17(4-5):241–247.
Taylor MJ, Lucier GW, Mahler JF, Thompson M, Lockhart AC,
Clark GC. 1992. Inhibition of acute TCDD toxicity by treat-
ment with anti-tumor necrosis factor antibody or dexa-
methasone. Toxicol Appl Pharmacol 117:126–132.
Vena J, Boffetta P, Becher H, Benn T, Bueno-de-Mesquita HB,
Coggon D, et al. 1998. Exposure to dioxin and nonneoplastic
mortality in the expanded IARC international cohort study of
phenoxy herbicide and chlorophenol production workers
and sprayers. Environ Health Perspect 106(suppl 2):645–653.
Vogel CF, Sciullo E, Wong P, Kuzmicky P, Kado N, Matsumura F.
2005. Induction of proinﬂammatory cytokines and C-reactive
protein in human macrophage cell line U937 exposed to air
pollution particulates. Environ Health Perspect 113:1536–1541.
Wolfe WH, Michalek JE, Miner JC, Rahe A, Silva J, Thomas WF,
et al. 1990. Health status of Air Force veterans occupationally
exposed to herbicides in Vietnam. I. Physical Health. JAMA
264:1824–1831.
Diabetogenic action of dioxin among Vietnam veterans
Environmental Health Perspectives • VOLUME 114 | NUMBER 11 | November 2006 1683